Irritable bowel syndrome and endometriosis: diagnosis, similarities, and nutritional management
This paper reviews diagnostic challenges, overlapping symptoms, and nutritional management strategies, including the low FODMAP diet for IBS and a Mediterranean diet for endometriosis, for patients with these conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (17)
- A prospective study of dietary fat consumption and endometriosis risk via openalex
- Diagnostic delay for superficial and deep endometriosis in the United Kingdom via openalex
- Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet via openalex
- Food groups and nutrients consumption and risk of endometriosis: a systematic review and meta-analysis of observational studies via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Vitamin D status in endometriosis: a systematic review and meta-analysis via openalex
- W4214754424 via openalex
- W4296277377 via openalex
- W4385480033 via openalex
- W4385758677 via openalex
- W1704633808 via openalex
- W4386422985 via openalex
- W3001123314 via openalex
- W3005726781 via openalex
- W3119014425 via openalex
- W3137665815 via openalex
- W3194401096 via openalex
Cited by (3)
- Intestinal endometriosis: Current aspects of pathogenesis, clinical picture, and differential diagnosis (a review of foreign literature) 2026
- Antagonizing the corticotropin-releasing hormone receptor 1 with an orally bioavailable drug reduces endometriosis pain and associated adhesions† 2026
- Antagonizing the corticotropin-releasing hormone receptor 1 with an orally bioavailable drug reduces endometriosis pain and associated adhesions† 2026
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-13T06:09:00.110300+00:00